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1. Introduction 
Recent studies have indicated that strict glycemic control is a very important factor for 
reducing maternal and fetal complications related to diabetic pregnancies (Metzer et al, 
2007; Kitzmiller et al, 2008), both in cases of pregestational diabetes (types 1 and 2) and in 
cases of diabetes diagnosed during pregnancy (gestational diabetes mellitus, GDM). It is 
often difficult to ensure a good metabolic control in these patients, however, due not only to 
their diabetes per se, but also to a number of practical problems. Pregnant diabetic women 
need frequent contact with their physician, not only for routine care but also to clarify their 
doubts arising, for instance, from sudden changes in their glycemic levels that need short-
lived adjustments to their therapy. Attending Metabolic Care Units can also prove difficult 
for various reasons (for women living too far away, or with no independent means of 
transportation, or needing to rest to avoid preterm delivery). 
In principle, telemedicine could be a useful method to apply to the care of diabetic women, 
but few studies have been published on this topic so far, the most important of which are 
discussed below. 
2. Telemedicine systems 
An adequate communication structure is fundamental to optimal interaction and 
coordination between caregivers, and between caregivers and patients. Information and 
communication technology (ICT) has the potential to solve certain problems in the 
management of diabetes care because it can enhance care coordination and support patient 
self-care. The chance to exploit ICT can reduce the costs while maintaining the quality of 
health care, and the fact that ICT can help respond to an increasing demand for care with a 
decreasing availability of personnel is of real interest.  
Previous reviews on diabetes care reported modest benefits of ICT-based care compared to 
conventional face-to-face care, but they focused primarily on the technology’s usability and 
mainly considered one-sided issues such as clinical improvements (glucose and diet) rather 
than looking at the diabetic patients’ various problems, including the influence of interactive 
technology on the caregiving process (patient-caregiver cooperation, care coordination, 
costs), the patient’s quality of life and self-care (Ouwens et al, 2005; Jennett et al, 2003; Balas 
et al, 1997). 
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ICT-based care is not just a technological tool, it is a different way to provide health care 
with the aid of ICT. The most important ICT-based care modalities are teleconsultation and 
videoconferencing. Teleconsultation is a form of telemonitoring involving patient-caregiver 
communication (monitoring and delivering feedback) via email, phone, automated 
messaging systems or other equipment without face-to-face contact, or the Internet. 
Videoconferencing involves real-time, face-to-face contact (image and voice) using 
videoconferencing equipment (television, digital camera, videophone, etc) to connect 
caregivers and one or more patients simultaneously, usually to provide instruction.  
In a recent review, Verhoeven et al showed that teleconsultation programs, with daily 
clinical data monitoring, providing education and personal feedback, are the most 
successful in inducing behavioral changes and containing costs. The benefits of 
videoconferencing related to its effects on socio-economic factors such as education and cost 
reduction, but also on disease monitoring.  Videoconferencing also seemed to be able to 
assure a good quality of care while achieving cost savings. 
The studies selected for review suggest that both teleconsultation and videoconferencing are 
practical, cost-effective and effective ways of delivering a health care service to diabetics, 
although the diversity of study designs and reported findings makes it impossible to draw 
any final conclusions. Interactive systems integrating patient monitoring and personalized 
feedback functions warrant further development in diabetes care in the near future. 
3. Studies on pregnancy 
Few studies have reported to date on the application of telemedicine to diabetic pregnancies 
(Tables 1 and 2). 
3.1 Studies on type 1 diabetes in pregnancy 
Di Biase et al investigated whether the use of telemedicine could be useful in the 
management of pregnant type 1 diabetic woman. A completely automated system (the 
DIANET system) was used and 20 type 1 pregnant women participated in the study: 10 
were treated using telemedicine and 10 using the conventional approach. The DIANET 
system was performed at 4 different times: “entry” (9.5 weeks), “basal” (9.5-16.8 weeks), “1st 
month” of investigation and “end” (near delivery). All the women adopted intensified 
insulin administration protocols. The DIANET ensured a better metabolic control than the 
conventional approach, judging from the profiles of the women’s absolute blood glucose 
values. These results were associated with higher insulin doses being used by women in the 
DIANET group, and a significant reduction in hypoglycemic episodes in both groups at the 
“end”, “1st month” and “basal” times with respect to “entry” time. On the basis of these 
results, the authors suggest that telemedicine (DIANET) is a practical way to provide 
specialist care in pregnancy. 
Frost et al studied whether diabetological care for pregnant women can be improved by 
using telemedicine, which facilitates communications between clinicians and patients. They 
adopted the prototype of a remote data management system (CareLink; Abbott-MediSense, 
New Bedford, MA) and 11 pregnant women with type 1 diabetes (all given intensified 
insulin therapy) were monitored with this system from the 15th gestational week onwards, 
in addition to providing the usual diabetological care, which consisted of regular 
outpatients visits every 2-3 weeks. A control group was formed of 10 pregnant women with 
type 1 diabetes with comparable age, diabetes duration, self monitoring practice, and insulin 
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regimen, who received standard diabetological care during the same time period as the 
CareLink group, but without the addition of telemedicine. 
The mean time between 2 visits was 3.3 weeks for the CareLink group and 2.9 weeks for the 
control group. HbA1c  improved in the CareLink group from 6.1 ± 1.0 to 5.4 ± 0.3% and in 
the control group from 6.2 ± 0.8 to 5.7 ± 0.6% (the difference between the two groups was 
not significant). Mean blood glucose (all values) in the CareLink group dropped from 141 ± 
90 to 110 ± 18 mg/dl, and mean fasting glucose from 111 ± 17 to 101 ± 23 mg/dl (P< 0.05). 
Blood glucose variability was also markedly reduced: the standard deviation in individual 
patients fell from 51.6 to 44.4 mg/dl (P<0.01) for mean blood glucose and from 41.4 to 31.0 
mg/dl for mean fasting glucose. There was no significant difference in the number of severe 
hypoglycemic episode in both groups during the study. The authors concluded that the 
system adopted for glucose monitoring is easy to use and helpful in the care of pregnant 
diabetic women, even when the patient attends the diabetes clinic less frequently. This 
telemedicine approach thus appears to be particularly suitable for women who have 
difficulty adhering to the prescribed regular check-ups at the clinic. 
Wojcicki et al evaluated the therapeutic effectiveness of a telematic intensive care system 
designed and applied for the intensive treatment of pregnant type 1 diabetic women. The 
system operates automatically, transferring every night all the data recorded in the patient’s 
glucometer memory during the day to a central clinical unit. To assess the efficiency of the 
system, a 3-year randomized prospective clinical trial was conducted, using a study group 
and a control group, each consisting of 15 pregnant type 1 diabetic women. All patients 
were treated by the same diabetologist. Two indices, calculated weekly, were used to assess 
glycemic control, i.e. mean blood glucose (MBG) levels and the universal J-index, which is 
sensitive to glycemia levels and their variations. The main results of the study were: a better 
glycemic control in the study group than in controls during the course of treatment, based 
on the mean differences in weekly MBG levels and J indices (n=24) (ΔMBG = -3.2 ± 4.3 
mg/dl, p = 0.0016, ΔJ = -1.4 ± 2.3, p = 0.0065); much more similar results in glycemic control 
among the women in the study group, than among those in the control group, as 
demonstrated by significantly lower variations in the glycemic control indices considered 
(SDMBG:11.9 vs 18.7 mg/dl, p = 0.0498; SDJ: 6.5 vs 10.9, p = 0.0318); a tendency for a better 
glycemic control in patients with a lower intelligence quotient (IQ < 100) using the telematic 
system than in all other assessed groups of patients. This last result was not statistically 
significant, however.  The telematic intensive care system thus improved the efficacy of 
diabetes treatment during pregnancy and enabled the diabetologist’s strategy to be much 
more precise than if it had been conducted without any telematic support.  
Ladyzynsky et al implemented a telematic system for supporting the intensive insulin 
treatment of pregnant type 1 diabetic outpatients and assessed the technical efficiency of the 
system. The system consisted of a patient teletransmission module (PTM) and a central 
clinical control unit (CCU). The PTM contained a one-box blood glucose meter and 
electronic logbook, a modem  and a dial-up or cellular phone set. The CCU consisted of a PC 
computer with a modem and DIAPRET – an original program designed to monitor intensive 
insulin treatment.  
The system was tested for 166 ± 24 days on 15 pregnant type 1 diabetic women. Patients’ 
data were telemonitored automatically. No major technical problems were noted. Total 
effectiveness (expressed as the percentage of days in which data were transmitted 
successfully from a patient’s PTM to the database in relation to the total number of days of 
the system application) was 69.3 ± 13.0% and technical effectiveness 91.5 ± 6.1%. The efficacy 
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of the system was not significantly influenced by the patient’s IQ, formal education or place 
of residence (p<0.05). There was a significant improvement in metabolic control while the 
system was in use. In short, the telematic system developed and implemented by the 
authors seems to have a positive influence on the quality of diabetes treatment during 
pregnancy. 
Ladyzynsky et al also examined the influence of a home telecare system on metabolic 
control in pregnant women with type 1 diabetes. The system stored blood glucose values 
and was integrated with a simple electronic logbook: the data collected by patients were 
automatically transmitted via the telephone network every night. Thirty patients with type 1 
diabetes were considered, randomly allocated to the home telecare group or to a control 
group treated by means of clinical check-ups every three weeks. In the home telecare group, 
the data collected by patients were transmitted to the hospital daily, enabling the doctor to 
take action more frequently. The mean study period lasted 180 days (SD 22) for the home 
telecare group and 176 days (SD 16) for the control group. The mean level of metabolic 
control and the insulin dosage adjustment patterns were similar for the two groups despite 
the much higher (15-fold) reporting frequency in the home telecare group. The data 
collected by patients were not fully utilized, mainly because of an excessively high within-
day variability in glycemic control and a high workload for daily data analysis. 
The mean frequency of reporting patient-collected data in the home telecare group was 0.7 
times a day (15 times more often than with routine care procedures), but the mean metabolic 
control was only slightly better in the home telecare group than in the control group, and 
the insulin dosage adjustments were similar. A possible explanation for the lack of any 
significant differences may relate to: general issues interfering with the day-to-day usage of 
the telecare system, such as a high workload associated with the daily data analysis or the 
physician’s attachment to conventional treatment methods; a marked variability in the 
glycemia of individual patients during the course of the day, masking medium-term 
changes in insulin requirements;  the study design and the characteristics of the study 
group. 
These findings led the authors to conclude that using a home telecare system during 
intensive insulin treatment for pregnant patients with type 1 diabetes improves glycemic 
control, but that real-time data transmission, accompanied by algorithms supporting data 
analysis and decision making, may be necessary to achieve further improvements in the 
quality of care. 
3.2 Studies on gestational diabetes mellitus (GDM) 
As for GDM patients, in a preliminary paper, Hernando et al proposed a method for 
assessing the performance of DIABNET, a knowledge-based system designed to aid doctors 
with treatment planning in gestational diabetes. The system is a qualitative model, 
implemented using a Causal Probabilistic Network, that can detect insulin effectiveness on a 
daily basis: the DIABNET analyses monitoring data and then recommends quantitative 
adjustments to insulin therapy and qualitative dietary changes. 
The methodology includes: subjective analyses based on questionnaires and objective 
analyses based on quantitative comparisons of the system’s and experts’ proposal. The 
authors also reported the results of two approaches in which diabetologists evaluated the 
treatment recommendations provided by the DIABNET during the follow-up of 9 patients 
with gestational diabetes. The DIABNET detected the need to adjust the therapy in 92% of  
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Authors Study group Control group Results 
Di Biase et al 
(1997) 
DIANET system 
Regular 
ambulatory 
visits 
1. Better metabolic control and 
higher insulin doses in the study 
group. 
Frost et al (2000) CareLink system
Regular 
ambulatory 
visits 
1. No differences in HbA1c 
improvements between the two 
groups. 
2. MBG and MFG markedly lower 
in the study group. 
Wojcicki et al 
(2001) 
Telematic 
Intensive Care 
system 
Regular 
ambulatory 
visits 
1. Better glycemic control in the 
study group, as assessed by MBG 
and J-index variations. 
2. Significantly lower variations in 
the glycemic control indices 
applied in the study group. 
Ladyzynsky et al 
(2001) 
PTM and CCU 
system 
--- 
1. Significant improvement in 
metabolic control 
Ladyzynsky et al 
(2007) 
Home Telecare 
system 
Clinical 
examinations 
every 3 weeks
1. Similar levels of metabolic 
control and insulin adjustment in 
the two groups 
Table 1. Brief outline of the studies conducted on telemedicine for type 1 diabetes mellitus in 
pregnancy 
cases, demonstrating its appropriateness for automatically triggering an alarm. Around 80% 
of the system’s proposals were approved by the experts, whose review of the results enabled 
a characterization of the system’s performance in proposing changes to a patient’s 
treatment. This study demonstrated the usefulness of DIABNET as a decision-guiding tool 
in gestational diabetes. 
Pèrez-Ferre et al showed that the outcome of GDM after using a telecare approach is no 
worse than after traditional visits to the outpatients clinic. The authors  evaluated the 
feasibility of a telemedicine system based on  the Internet and txt messaging in pregnancy, 
and its influence on delivery and neonatal outcomes for women with GDM. A hundred 
GDM women were randomized to form two groups: a control group followed up with 
traditional check-ups at the outpatients clinic and a study group of women equipped with a 
telemedicine system for transmitting capillary glucose data and text messages and receiving 
weekly professional feedback. Ninety-seven women completed the study (48 controls and 
49 in the study group) and the rates of women with HbA1c values < 5.8%, normal vaginal 
deliveries and babies large for their gestational age (LGA) were evaluated. Women in the 
study group had more contacts with health personnel (15.09 vs 9.11), taking up less time (3.8 
vs 4.6 hours for each insulin-treated patient,  p<0.001). No significant differences were seen 
between the two groups in terms of HbA1c levels, normal vaginal delivery and LGA 
newborn.  The authors concluded that this system significantly reduced the need for 
outpatient clinic visits while achieving similar pregnancy, delivery, and newborn outcomes. 
More recently, the same authors demonstrated that, compared to a control group, a 
telemedicine group reduced by 62% the number of unscheduled face-to-face visits, and by 
82.7% in the subgroup of insulin-treated patients, improving patient satisfaction, and 
achieving similar pregnancy and newborn outcomes. 
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Homko et al randomized 57 indigent women with GDM to an Internet group (n=32) or a 
control group (n=25); patients in the Internet group were provided with computers and/or 
Internet access if necessary. A website was used to record glucose values and for 
communications between the patient and the healthcare team. The women in the control 
group kept paper logbooks, which were reviewed at each prenatal visit. Maternal feelings 
about “diabetes self-efficacy” were assessed at study entry and before delivery.   
The women in the Internet group accessed the system and sent a mean 21.8 (± 16.9) data 
sets. There was no difference between the two groups in terms of fasting or after-meals 
blood glucose values, though more women in the Internet group received insulin therapy 
(31% vs 4%; p< 0.05). There were also no significant differences in pregnancy and neonatal 
outcomes between the two groups. The women in the Internet group showed a significantly 
stronger sense of self-efficacy at the end of the study.  
The benefits of monitoring blood glucose in indigent women with GDM via the Internet was 
limited by their infrequent use of the telemedicine system. Although use of the system was 
not associated with better pregnancy outcomes, the women in the telemedicine group did 
experience a stronger sense of being self-sufficient in coping with their condition. 
 
Authors Study group Control group Results 
Hernando et al 
(2000) 
DIABNET system --- 
Two different experiments 
evaluated the system’s 
performance compared to 
physicians, based on answers to 
questionnaires and quantitative 
comparisons of the system’s and 
experts’ recommendations 
Pèrez-Ferre et al 
(2009) 
Telemedicine 
system (Internet 
and text messages)
Traditional 
face-to-face 
visits at the 
outpatient clinic
1. Women in the study group 
went significantly less to the 
outpatients clinic. 
2. No differences in HbA1c levels 
between the two groups  
3. No significant differences in 
delivery modality between the 
two groups 
4. No difference in the rate of 
LGA babies  between the two 
groups 
Homko et al 
(2007) 
Telemedicine 
system 
(website for 
recording of 
glucose values) 
Information 
recorded in a 
paper logbook
1. No differences between the two 
groups regarding fasting or after-
meals glucose values 
2. No significant differences in 
pregnancy or neonatal outcomes 
3. Study group patients had 
stronger “feelings of self-efficacy”  
Table 2. Short outline of studies on telemedicine for pregnancies complicated by gestational 
diabetes mellitus (GDM) 
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For our study, we considered 235 pregnant women (203 with GDM and 32 with type 1 
diabetes mellitus), who were trained to monitor their blood glucose levels with a glucometer 
(One Touch Ultra-Lifescan) and to send their glycemic profiles by means of a standard 
phone call to Glucobeep. The clinical and metabolic parameters we considered were age, 
pre-pregnancy BMI, mode and timing of delivery, macrosomia, maternal and fetal 
morbidity. Subjective outcomes were also investigated using the following questionnaires: 
CES-D for depression, SF-36 for health-related quality of life (QoL), Stress and Distress for 
the impact of diabetes.  
All the women were given standard care according to the Recommendations of the 
American Diabetes Association.  
They were sequentially assigned to two groups: one patient was followed up using the 
telemedicine approach (study groups: T for GDM, and T1 for diabetes type 1), and the next 
using the conventional approach (control groups: C for GDM and C1 for diabetes type 1). 
Women in groups T and T1 were trained on the use of the Glucobeep and asked to submit 
their glycemic data once a week, or more often if necessary, while they had a medical check-
up at the diabetes clinic once a month. Women in the C and C1 groups had a medical check-
up every two weeks. All patients could contact the physician whenever they wished (Table 3). 
 
 
T 
88 
C 
115 
T1 
17 
C1 
15 
Clinical parameters 
Age (yrs) 34.2±4.4 33.8±4.5 30.8±4.2 32.7±3.1 
GDM diagnosis (g.w.) 24.9±4.8 25.1±5.9 - - 
Duration of type 1 
diabetes (yrs)  
- - 16.1±7.7 17.4±5.8 
Prepregnancy BMI 25.0±5.2 25.1±5.9 23.3±4.2 24.9±4.8 
Weight gain (kg) 10.6±4.3 11.0±4.8 11.0±4.0 11.7±7.5 
HbA1c at booking (%) 5.1±0.5 5.2±0.5 7.5±1.2 7.1±1.1 
HbA1c in 3rd trim.(%) 5.1±0.6* 5.3±0.5 6.7±0.7 6.5±0.8 
Insulin therapy (%) 48 39.1 100 100 
Pregnancy outcome 
Delivery (g.w.) 38.8±1.5 38.7±1.8 36.1±1.9 35.1±7 
Cesarean section (%) 38.6° 53.0 70.6 73.3 
Maternal morbidity (%) 3.4 6.9 29.4 13.3 
Birth weight (g) 3268±531 3249±566 3307±698 3467±686 
Neonatal morbidity (%) 7.9 5.2 47.2 40.0 
Macrosomia (%) 4.6 6.7 23.5 20 
Table 3. Clinical and metabolic parameters, and pregnancy outcomes in  32 pregnant type 1 
diabetic women, 17 of them followed up with the telemedicine system (T1), 15 using the 
traditional approach (C1), and in 203 GDM women, 88 of them followed up with the 
telemedicine system (T) and 115 with the traditional approach (C) * p = 0.008 T vs C;   
° p = 0.02 T vs C. 
Women with diabetes type 1 were enrolled in the study at their first visit after conception, 
while women with GDM were included a week after GDM was diagnosed (after a mean 
28±1 weeks of gestation). 
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Type 1 diabetic pregnant women revealed no differences in clinical and metabolic 
parameters, or pregnancy outcomes, whether they were followed up with the telemedicine 
system or conventionally. 
Conversely, the GDM women followed up with the telemedicine system had a better 
metabolic control, as demonstrated by their HbA1c levels at the end of the pregnancy 
(p=0.008), a lower rate of caesarean sections (p=0.02), and also of macrosomia (though the 
difference was not statistically significant) than the GDM women followed up 
conventionally. 
Using the telemedicine approach for pregnant type 1 diabetic women resulted in fewer 
visits to the diabetes clinic. Most women reported being satisfied with the system because 
they could contact the physician whenever they felt it necessary to do so.  
As for GDM patients, the telemedicine approach led to improvements in their metabolic 
control and in some maternal and fetal outcomes. Our data differ from the report from 
Homko et al, who found no significant differences in pregnancy and neonatal outcome 
between GDM women followed up with a telemedicine approach and those in conventional 
care, but their patients’ poor economic conditions and scarce adherence to the study may 
well explain the different results they obtained. 
To our knowledge, our study is the first to examine the influence of telemedicine systems on 
quality of life in diabetic pregnant women. We were unable to document any major 
differences between the study group and controls, but the scores for some areas explored by 
the SF-36, e.g. general health perception, vitality and mental health, improved significantly 
after delivery only in the telecare group, suggesting a positive impact of the system on 
subjective health perception. In both groups, the diabetes-related frustration and worry 
decreased markedly after delivery, physical functioning substantially improved, and 
women perceived fewer role limitations as a result of their physical problems.  
A strength of our study is that we adopted a straightforward telemedicine system (using the 
telephone) that was easy for all patients to handle, demanding no IT expertise or computer 
literacy.  
Use of the telemedicine system was associated with a positive impact on quality of life. The 
system also reduced the number of visits to the diabetes clinic and helped the diabetic 
women to maintain a better metabolic control with fewer medical consultations. 
4. Conclusions 
In conclusion, the above-reported studies all show that the telemedicine approach can be a 
practical way to provide specialist care in pregnancies complicated by diabetes. 
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Innovative developments in information and communication technologies (ICT) irrevocably change our lives
and enable new possibilities for society. Telemedicine, which can be defined as novel ICT-enabled medical
services that help to overcome classical barriers in space and time, definitely profits from this trend. Through
Telemedicine patients can access medical expertise that may not be available at the patient's site.
Telemedicine services can range from simply sending a fax message to a colleague to the use of broadband
networks with multimodal video- and data streaming for second opinioning as well as medical telepresence.
Telemedicine is more and more evolving into a multidisciplinary approach. This book project "Advances in
Telemedicine" has been conceived to reflect this broad view and therefore has been split into two volumes,
each covering specific themes: Volume 1: Technologies, Enabling Factors and Scenarios; Volume 2:
Applications in Various Medical Disciplines and Geographical Regions. The current Volume 2 is structured into
the following thematic sections: Cardiovascular Applications; Applications for Diabetes, Pregnancy and
Prenatal Medicine; Further Selected Medical Applications; Regional Applications.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Annunziata Lapolla, Nino Cristiano Chilelli and Maria Grazia Dalfra (2011). Telemedicine in Pregnancy
Complicated by Diabetes, Advances in Telemedicine: Applications in Various Medical Disciplines and
Geographical Regions, Prof. Georgi Graschew (Ed.), ISBN: 978-953-307-161-9, InTech, Available from:
http://www.intechopen.com/books/advances-in-telemedicine-applications-in-various-medical-disciplines-and-
geographical-regions/telemedicine-in-pregnancy-complicated-by-diabetes
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
